🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07747428
Recruiting Observational

Assessment of Retinal Microvascular Changes by OCT Angiography in Diabetic Retinopathy

NCT07747428 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2026-01-01
Last updated
2026-08-05

Condition(s) studied

Diabetic Retinopathy

Study summary

This observational cross-sectional study aims to assess retinal microvascular changes using optical coherence tomography angiography (OCTA) in patients with diabetic retinopathy. The study will evaluate retinal vessel density and foveal avascular zone parameters and investigate their correlation with best-corrected visual acuity and glycemic control (HbA1c) across different stages of diabetic retinopathy. The findings may improve understanding of retinal microvascular alterations and their clinical significance.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: \- Inclusion Criteria: * Adults aged 18 to 80 years. * Patients diagnosed with diabetic retinopathy. * Ability to undergo complete ophthalmic examination including OCT and OCT angiography. * Availability of HbA1c measurement within the study period. * Ability and willingness to provide written informed consent. Exclusion Criteria: * Previous vitreoretinal surgery. * Significant media opacity affecting image quality (e.g., dense cataract or vitreous hemorrhage). * Other retinal vascular diseases (e.g., retinal vein occlusion). * Glaucoma or optic nerve diseases affecting visual function. * High myopia (\>6 diopters). * Poor-quality OCTA images due to motion artifacts or poor fixation. * Refusal or inability to provide informed consent. Exclusion Criteria: \-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sohag Ophthalmology Hospital Sohag Egypt Recruiting

More Sohag University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07747428 on ClinicalTrials.gov ↗ ← All trials in Egypt